2024 peptide APIs product list
The company is a high-tech enterprise with core technologies for peptide synthesis and modification, with advanced and efficient peptide drug technology research and development and large-scale production capabilities.
The company’s main business is independent research and development, production and sales of peptide APIs and preparations with large market capacity and strong competitiveness at home and abroad. Foreign pharmaceutical companies provide pharmaceutical research services for polypeptide innovative drugs, customized production services for polypeptide products, and transfer services for polypeptide drug production technology.
In addition, the company also provides the processing of small molecule chemical drug levosimendan preparations and the production and export sales of levosimendan raw materials.
The company has a full-process R&D pipeline and a full-industrial chain platform for peptide APIs and preparations, and can provide pharmaceutical research services from process route design, small test, pilot test, process validation and quality research for innovative peptide drugs and generic drugs, and Full-chain customized production services for APIs and preparations required for drug R&D and commercial production, covering the complete drug development cycle from drug discovery, preclinical research, to clinical trials and marketing.
Relying on the core technology advantages of peptide synthesis and modification, the company has gained high popularity and recognition in the field of peptide drug R&D and production. For the pharmaceutical research and customized production services of more than 10 projects, 1 innovative peptide drug has been approved and entered the commercialization stage, and another 7 innovative peptide drugs have entered the clinical trial stage.
The company selects peptide generic drug varieties with large market capacity and strong market competitiveness at home and abroad for research and development, and has mastered the large-scale production technology of 15 varieties of APIs, of which 7 varieties have obtained production approvals in China, and 8 varieties have obtained domestic production approvals.
Obtained the U.S. DMF filing (activation status), and obtained 12 domestic production approvals for 8 peptide preparation varieties developed by extension, covering immunity, digestive tract, antiviral, obstetrics and gynecology, diabetes, cardiovascular and cerebrovascular, rare diseases, orthopedics and other fields where peptide drugs play an important role.
The company’s polypeptide preparation products, enfuvirtide for injection and carbetocin injection, are the first domestic imitation polypeptide drugs; The more difficult generic APIs have been exported to Europe, America, India, South Korea and other international markets, and end customers include Fresenius, Aurobindo, Mylan, Lupin, Xin Litai, Shanghai Pharma First Biochemical, Yangtze River and other well-known pharmaceutical companies at home and abroad;
the industrial R&D of five varieties of atosiban acetate, octreotide acetate, somatostatin, thymosin and carbetocin were included in the “” The Eleventh Five-Year “National Major New Drug Creation Project”; the two preparations of icatibant and posaconazole that the company has submitted for drug registration were included in the “First Batch of Encouraged Generic Drug List” by the National Health Commission.
The company has 25 invention patents (one of which has obtained an international patent at the same time) and a large number of non-patented technologies, and has been awarded more than ten national and provincial scientific research and technological transformation projects. “Drug Engineering Technology Research Center”, was rated as “Sichuan Enterprise Technology Center” by Sichuan Economic and Information Commission, and played an important role in the development and industrialization of peptide drugs in my country.
Other Polypeptide APIs Products
peptide synthesis companies
| Polypeptide APIs Products |
| US-DMF LIST |
| Beauty peptides |
| Chinese cGMP APIs |
| Mexico Registered APIs |
| Research Peptide APIs for Regulatory Market |
| Polypeptide Preparation |
| Kaijie bio medicine Peptide APIs |